Core Papers

What’s New in the Diagnosis of Immune Skin Diseases (Blistering Diseases)?

What’s New in the Diagnosis of Immune Skin Diseases (Blistering Diseases)?

Ken Ishii and Masayuki Amagai
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan

Published:  07 January 2008

 

Summary

Since molecular targets of autoantibodies in autoimmune blistering diseases were identified, several new serodiagnostic assays have been developed. Desmoglein 1 and 3 ELISA (enzyme linked immunosorbent assay) for pemphigus, and BP180 and BP230 ELISA for pemphigoid are available. These assays enable a rapid characterization of patients' sera.

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here

return to core papers list